MCL1 and invasive breast carcinoma: To validate the performance of Andy’s DAB+ IHC algorithm, a subset of 27 TMAs cores was selected with invasive breast cancer showing both nuclear (11 cores) and cytoplasmic (16 cores), MCL-1 expression was compared the output of Andy’s DAB+ IHC pipeline with that of the pathologist.